First Patient Dosed in a Phase III Trial of Anti-PD-1 Antibody as First-line Treatment for Patients with Non-Squamous Non-Small Cell Lung Cancer Sep 11, 2018 Life Science
Tianjin Tasly Out-licenses US Rights to TCM Angina Drug in $50 Million Deal Sep 11, 2018 Life Science
Eastwood Bio-medical Canada Inc. Announces Product Approvals from the South Korean Government and Initial Shipment of Products to Korea Sep 10, 2018 Life Science
Life Science & Technology Weekly 159 – RootPath Receives $7 Million Seed Funding for Next-Gen Immuno-Oncology Sep 6, 2018 Life Science, Technology
Miracor Medical closes final tranche of Series-D, bringing the round to €30M Sep 5, 2018 Life Science
Naturally Splendid Provides Update On Clearstream Cannabis Related Securities List Sep 5, 2018 Life Science
Eastwood Bio-medical Canada Inc. Introduces New Cannabis and Cholesterol Products Sep 5, 2018 Life Science
